JADE201 builds on clinical proof-of-concept for BAFF-R targeting, adding half-life extension technology to provide extended ...
The Neuromuscular Disease Therapeutics Market is entering a period of accelerated growth, supported by breakthroughs in gene ...
From bispecific engineering to clinically relevant data sourcing, evolving antibody technologies advance oncology therapeutics.
Hospitalizations due to RSV cases in infants are reduced by up to 43% following the introduction of new maternal vaccines.
A groundbreaking universal snake antivenom, derived from rare human antibodies, offers hope against deadly bites worldwide.
Researchers evaluated whether interferon-α nasal spray reduces the incidence of COVID-19 or other respiratory viral infections among adults with cancer.
A promising new treatment for Lyme disease, a condition transmitted through tick bites, is in development and aims to offer ...
THIRUVANANTHAPURAM: Taking a significant step forward in haemophilia care, the health department is set to establish a ...
Enzyme Replacement Therapy (ERT) generated over US$ 46 billion in 2024, driven by established treatments for Gaucher disease, ...
Jade Biosciences (JBIO) unveiled JADE201, its investigational half-life extended, afucosylated monoclonal antibody targeting the B-cell activating ...
Black mamba venom's dual-paralysis effect can cause worsening symptoms even after antivenom treatment. Researchers found it ...
Scientists have discovered a potential new way to target Alzheimer's disease in the brain. The technique improved cognitive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback